| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.201500490 |
| P698 | PubMed publication ID | 26683881 |
| P50 | author | Jörg Pabel | Q73375603 |
| Klaus Theodor Wanner | Q87805156 | ||
| P2093 | author name string | Marilena Petrera | |
| Georg Höfner | |||
| Lars Allmendinger | |||
| Thomas Wein | |||
| Miriam Sindelar | |||
| P2860 | cites work | Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates | Q73138368 |
| (Cyanomethyl)trialkylphosphonium iodides: efficient reagents for the intermolecular alkylation of amines with alcohols in solution and on solid phase | Q73700797 | ||
| MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1 | Q80067141 | ||
| Ruthenium-catalyzed cyclization of 2-alkyl-1-ethynylbenzenes via a 1,5-hydrogen shift of ruthenium-vinylidene intermediates | Q80084537 | ||
| Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors | Q82759303 | ||
| Application of MS Transport Assays to the Four Human γ-Aminobutyric Acid Transporters | Q85667285 | ||
| Amino acid substitution matrices from protein blocks | Q24563220 | ||
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma | Q27693823 | ||
| Identification of common molecular subsequences | Q27860816 | ||
| GROMACS: fast, flexible, and free | Q27860998 | ||
| GABA transporter heterogeneity: pharmacology and cellular localization | Q28297945 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Statistical potential for assessment and prediction of protein structures | Q29615145 | ||
| Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters | Q29616590 | ||
| Generation of a 3D model for human GABA transporter hGAT-1 using molecular modeling and investigation of the binding of GABA. | Q30377894 | ||
| Molecular biology of mammalian plasma membrane amino acid transporters | Q34067787 | ||
| Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects | Q34087979 | ||
| Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice | Q34175243 | ||
| The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface. | Q34231212 | ||
| Deletion of the γ-aminobutyric acid transporter 2 (GAT2 and SLC6A13) gene in mice leads to changes in liver and brain taurine contents | Q34294297 | ||
| Focused pseudostatic hydrazone libraries screened by mass spectrometry binding assay: optimizing affinities toward γ-aminobutyric acid transporter 1. | Q34323584 | ||
| The GROMOS software for biomolecular simulation: GROMOS05. | Q34457783 | ||
| Mechanism of chloride interaction with neurotransmitter:sodium symporters. | Q34664153 | ||
| Identification of a chloride ion binding site in Na+/Cl -dependent transporters. | Q35921659 | ||
| The role of structure activity relationship studies in the search for new GABA uptake inhibitors | Q37294449 | ||
| Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs | Q37660687 | ||
| A medicinal chemist's guide to molecular interactions | Q37719514 | ||
| Cost of disorders of the brain in Europe 2010. | Q37933664 | ||
| Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4. | Q39994283 | ||
| Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature | Q41775672 | ||
| Orally active and potent inhibitors of gamma-aminobutyric acid uptake | Q42204834 | ||
| Homology modelling of the GABA transporter and analysis of tiagabine binding | Q42661394 | ||
| 5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCtheta: optimization of enzymatic and functional activity | Q43250144 | ||
| Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives | Q43764148 | ||
| Treating refractory epilepsy with tiagabine: clinical experience | Q45026891 | ||
| Major human gamma-aminobutyrate transporter: in silico prediction of substrate efficacy | Q46925934 | ||
| Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds | Q48427274 | ||
| Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function | Q56885198 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 519-538 | |
| P577 | publication date | 2015-12-18 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives by Suzuki-Miyaura Cross-Coupling Reactions | |
| P478 | volume | 11 |
| Q51167808 | Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents. |
| Q48144959 | Development of Non-GAT1-Selective Inhibitors: Challenges and Achievements |
| Q61805435 | GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitors |
| Q90431734 | N-Substituted Nipecotic Acids as (S)-SNAP-5114 Analogues with Modified Lipophilic Domains |
| Q92921913 | Synthesis and Biological Evaluation of Nipecotic Acid and Guvacine Derived 1,3-Disubstituted Allenes as Inhibitors of Murine GABA Transporter mGAT1 |
Search more.